Name:mycCav1fixF Sequence:CCG CAT CAA CTT GCA GAA AGA AAT ATA GTA ACT CGA GTC TAG AGG GCC Product:25… and 3 more items

The University of Virginia awarded contract A207_PO-0445531 to Integrated DNA Technologies Inc. on June 4, 2026, for the procurement of synthesized deoxyribonucleic acid (DNA) oligonucleotides. The contract, valued at thirty-six dollars, encompasses four distinct DNA oligo products with standard desalting purification, each ordered in a quantity of one unit. The line items consist of two complementary oligonucleotide pairs: mycCav1fixF and mycCav1fixRev sequences (each containing 48 bases at $9.67 per unit), and mycSpurfixF and mycSpurfixRev sequences (each containing 43 bases at $8.66 per unit). All items are specified as 25 nanomole DNA oligos and are designated for delivery to Yelena Peskova.

This procurement represents a small-dollar purchase of molecular biology reagents by the University of Virginia, a state institution in Virginia. The contract does not specify an explicit contract performance period; however, the award date of June 4, 2026, marks the contract execution date. The minimal contract value and the specific molecular sequences ordered suggest this is a research support purchase, likely for laboratory use at the university. No separate line item quantities or alternative unit of measure specifications were provided beyond the individual oligonucleotide products listed.